The effect of dexmedetomidine as an adjuvant to bupivacaine in ultrasound-guided quadratus lumborum block for postoperative analgesia in laparoscopic cholecystectomy: a randomized controlled trial
Tanta Medical Journal · 2026-04 · 54 (2) · 165-169
DOI: 10.4103/tmj.tmj_50_25 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Tanta Medical Journal, online erschienen am 20.04.2026. Verfasst von Waleed N. El Said und 3 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Dexmedetomidine (DEX), an alpha-2 agonist, supplements local anesthetics in neuraxial and peripheral nerve blocks. This study examined the effects of adding DEX to bupivacaine in ultrasonography-guided quadratus lumborum block (USG-QLB) for postoperative analgesia in laparoscopic cholecystectomy (LC).
Aim
To evaluate the effect of adding DEX as an adjuvant to bupivacaine in USG-QLB for postoperative analgesia in LC. Patients and methods This prospective randomized controlled double-blinded study included 96 elective LC patients aged 21–65 of both sexes. Group I (bupivacaine group) received general anesthesia and bilateral USG-transmuscular QLB (TMQLB) with (20 ml bupivacaine 0.25%). Group II (bupivacaine+DEX group) received general anesthesia and bilateral USG-TMQLB with (20 ml bupivacaine 0.25%+DEX 1 μg/kg).
Results
Group II had significantly lower mean arterial blood pressure following surgery compared to group I, with no significant differences before or after skin incision (5, 15, or 30 min). Group II, lower heart rate changes after skin incision compared to group I. Group II had smaller change in the numerical rating scale at 6, 12, and 18 h compared to group I, but no significant difference immediately after discharge. In group II, intraoperative fentanyl and postoperative morphine were significantly lower than in group I.
Conclusion
DEX added to bupivacaine in USG-TMQLB for LC enhanced analgesia and hemodynamic stability by lowering mean arterial blood pressure, heart rate, and pain ratings, reducing opioid consumption, and delaying rescue analgesia.
Zitieren
APA
Said, W. N. E., Kashef, A. M. E., Abdelghany, M. S., & Okab, M. I. (2026). The effect of dexmedetomidine as an adjuvant to bupivacaine in ultrasound-guided quadratus lumborum block for postoperative analgesia in laparoscopic cholecystectomy: a randomized controlled trial. Tanta Medical Journal, 54(2), 165-169. https://doi.org/10.4103/tmj.tmj_50_25
Vancouver
Said WNE, Kashef AME, Abdelghany MS, Okab MI. The effect of dexmedetomidine as an adjuvant to bupivacaine in ultrasound-guided quadratus lumborum block for postoperative analgesia in laparoscopic cholecystectomy: a randomized controlled trial. Tanta Medical Journal. 2026;54(2):165-169. doi:10.4103/tmj.tmj_50_25
BibTeX
@article{Said2026,
author = {Said, Waleed N. El and Kashef, Ahmed M. El and Abdelghany, Mohamed S. and Okab, Mohamad I.},
title = {The effect of dexmedetomidine as an adjuvant to bupivacaine in ultrasound-guided quadratus lumborum block for postoperative analgesia in laparoscopic cholecystectomy: a randomized controlled trial},
journal = {Tanta Medical Journal},
year = {2026},
volume = {54},
number = {2},
pages = {165--169},
doi = {10.4103/tmj.tmj_50_25}
}
EUVIMED